why choose us

First received: January 05, 2024

Clinical Trial: A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Solid Tumor (Phase 1)

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2a Study of IMM-6-415 in Participants With Advanced or Metastatic Malignancies Harboring RAS or RAF Oncogenic Mutations

Brief Summary: This is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with advanced or metastatic solid tumors harboring RAS or RAF oncogenic mutations.

Read more